The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 22 of the 35 sources its claims cite were checked for support.
Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system
Open accessAbstract
ObjectivesRemote patient monitoring (RPM), combining home blood pressure measurements with telehealth services, effectively manages hypertension. Successful implementation of RPM programs at scale requires understanding program costs and financial sustainability. We evaluated the financial performance of an RPM program.MethodsConducted from March to June 2024 in the Cardiology Division at New York University Langone Health, the study used field observation, surveys, and micro-costing methods. A costing tool was developed to quantify program costs in 2024 US dollars, including personnel, equipment, and supplies. RPM-related services reimbursement rates were estimated using Medicare billing information. The return-on-investment (ROI) ratio was calculated by dividing net return (profit) by the RPM program costs. Sensitivity analyses assessed the impact of varying parameters on the ROI of RPM.ResultsThe average RPM program cost was estimated at $330 per patient (range: $208-$452). Major expenses included data review by staff ($172 per patient), blood pressure devices ($48 per patient), and phone communications ($36 per patient). ROI varied based on patient compliance with home blood pressure monitoring (≥16 days per month), with an average estimate of 22.2% (range: -11.1%-93.3%) per patient at a 55% compliance rate. The ROI was most sensitive to changes in data-review costs, insurance reimbursement rates, patient compliance, device setup, and communication costs.ConclusionsThe RPM program achieved a positive ROI from the perspective of a clinical division in a large healthcare system. Successful implementation and financial sustainability of RPM require efforts to reduce human resource costs and enhance patient engagement.
Overview
CoChat Summary
TL;DR
This economic evaluation of a remote patient monitoring for hypertension (RPM-HTN) program in the Cardiology Division at NYU Langone Health estimated an average program cost of $330 per patient and an average per-patient ROI of 22.2% at 55% compliance. It concludes the program achieved a positive short-term ROI from the clinical division perspective, with financial performance most sensitive to data-review costs, insurance reimbursement, and patient compliance.
Key findings
- The average RPM-HTN program cost was $330 per patient (range: $208–$452), with projected total cost for 100 patients of $32,977 (range: $20,785–$45,168). Major costs were NP review of home BP data at $172 per patient (52.1% of expenses), Bluetooth-enabled BP devices at $48, and monthly phone communication at $36.
- Average per-patient ROI was 22.2% (range: −11.1% to 93.3%) at a 55% compliance rate, meaning $1.22 returned per dollar invested. At the division level, base-case ROI was 19.5% (range: −12.8% to 89.5%), and estimated Medicare reimbursement per patient was $402.
- Sensitivity analyses found the most influential factor was BP data-review cost ($86–$258; EV range −$13 to $159), followed by insurance reimbursement ($292–$525; EV range −$16 to $77), patient compliance (0.4–0.8; EV range $73–$128), device setup, and NP follow-up costs.
- Other cost components included enrollment/consent/education at $29 per patient, annual Validic application depreciation at $23 per patient, staff training at $0.42 annually, and supplies at $1.70 per patient one time.
Methods
- The study used activity-based micro-costing from March to June 2024 in the Cardiology Division at NYU Langone Health, combining field observation, staff surveys, and retrospective de-identified aggregated EHR data for 100 patients enrolled in RPM-HTN from January 1 to December 31, 2023. The sample had a median age of 66 years (range: 28–87), 30% male, and 52% covered by Medicare.
- Costs were quantified in 2024 US dollars across personnel, program start-up, equipment, supplies, and miscellaneous categories. Revenue was estimated using the 2024 Medicare physician fee schedule for CPT codes 99453, 99454, 99457, and 99458, adjusted for New York with a rate of 1.061.
- ROI was calculated as (total revenue − total cost) / total cost × 100%. Sensitivity analyses varied personnel time and hourly rates, patient compliance, insurance reimbursement rates, device setup, communication costs, and emergency-event probability.
Limitations
- The paper states that ROI was estimated using Medicare reimbursement rates even though many patients have private insurance or Medicaid with varied policies; Medicare rates are state-specific; the analysis assessed only short-term ROI with an average enrollment duration of four months; no prospective cohort or implementation process measures were collected; only direct program costs and revenues were included, excluding system-level impacts; and estimates reflect one clinical division and the healthcare system perspective, limiting generalizability.
- The paper also states that future studies should integrate patient and payer perspectives, assess patient-centered outcomes, and evaluate longer-term economic value.
- Evident from the text: the analysis relies on a small retrospective sample of 100 patients in a single cardiology division, uses staff self-reports and aggregated de-identified data, and does not capture long-term health outcomes or broader societal costs and savings.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 3 Not valid · 7 Not checked · 54 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The ROI of RPM depends on the specific clinical setting and available resources.7,24,25”
§ Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system > Discussion
What the sources say
- Not checked — no full text of the sourcecites [7] De Guzman KR, Snoswell CL, Taylor ML, Economic evaluations of remote patient monitoring for chronic disease: a systematic review. Value Health 2022; 25: 897– 913. 35667780 source
- Partly supportedcites [24] Shantharam SS, Mahalingam M, Rasool A, Systematic review of self-measured blood pressure monitoring with support: Intervention effectiveness and cost. Am J Prev Med 2022; 62: 285– 298. 34686388 PMC8748385 sourceExperimental — accuracy not yet measured
The Results (Intervention Effect, Cost, and Cost per Unit of Effectiveness; page unavailable) associate some intervention features with differences in cost and cost per unit of effectiveness for supported self-measured blood-pressure monitoring. The paper does not calculate return on investment or establish that ROI for RPM generally depends on clinical setting and available resources. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [25] MacLeod KE, Chapel JM, McCurdy M, The implementation cost of a safety-net hospital program addressing social needs in Atlanta. Health Serv Res 2021; 56: 474– 485. 33580501 PMC8143691 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Patient compliance is one of the most critical factors influencing the ROI and sustainability of the RPM-HTN program.24”
§ Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system > Discussion
What the sources say
- Could not verifycites [24] Shantharam SS, Mahalingam M, Rasool A, Systematic review of self-measured blood pressure monitoring with support: Intervention effectiveness and cost. Am J Prev Med 2022; 62: 285– 298. 34686388 PMC8748385 sourceExperimental — accuracy not yet measured
The Results (Intervention Features; page unavailable) describe support for medication adherence, and the Results (Intervention Effect, Cost, and Cost per Unit of Effectiveness; page unavailable) associate technologies that facilitate patient engagement with greater effectiveness. Neither passage evaluates patient compliance as a factor in return on investment or program sustainability. Searches for compliance, return on investment, and sustainability found no passage making that claim. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“one study showed that a $1.00 increase in Medicare’s fees increases corresponding private prices by $1.16,37”
§ Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system > Discussion
What the sources say
- Supportedcites [37] Clemens J and Gottlieb JD. In the shadow of a giant: Medicare’s influence on private physician payments. J Polit Econ 2017; 125: 1– 39. 28713176 PMC5509075 source
The paper’s Abstract states the claimed $1.16 increase directly. Section VI.A identifies it as the baseline IV estimate: a $1.00 change in actual Medicare payments for a service leads to a $1.16 change in private payments for that service. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“another study found that in 2020, employers and private insurers paid 224 percent of what Medicare would have paid for the same services.38”
§ Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system > Discussion
What the sources say
- Supportedcites [38] Whaley CM, Briscombe B, Kerber R, Prices paid to hospitals by private health plans: findings from round 4 of an employer-led transparency initiative. Rand Health Quart 2022; 10: 5. PMC9718062 36484073 source
The paper’s Key Findings state that in 2020, employers and private insurers paid 224 percent of what Medicare would have paid for the same services at the same facilities. The figure covers hospital inpatient and outpatient services, including facility and related professional charges. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, using artificial intelligence (AI) to perform tasks currently handled by NPs,29 such as sending personalized feedback, reminders to submit BP records, nudging patients to take medications, and scheduling appointments for elevated BP, can improve patient adherence and compliance in remote monitoring.30”
§ Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system > Discussion
What the sources say
- Partly supportedcites [29] Joachim S, Forkan ARM, Jayaraman PP, A nudge-inspired AI-driven health platform for self-management of diabetes. Sensors 2022; 22: 4620. 35746402 PMC9227220 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [30] Tai-Seale M, Baxter SL, Vaida F, AI-Generated draft replies integrated into health records and physicians’ electronic communication. JAMA Network Open 2024; 7: e246565– e246565. 38619840 PMC11019394 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
41 more claims · 1 with their cited sources checked
Create a free account to see all 75 claims and every source verdict.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 14
Citations
Cites
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Green, B. B. (2008) · JAMA · doi:10.1001/jama.299.24.2857 · Cited by 659
Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., Earle, K., George, J., Godwin, M., Green, B. B., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002389 · Cited by 658
Dunn, A., Grosse, S. D., & Zuvekas, S. H. (2018) · Health Services Research · doi:10.1111/1475-6773.12612 · Cited by 494
In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments
Clemens, J., & Gottlieb, J. D. (2017) · Journal of Political Economy · doi:10.1086/689772 · Cited by 316 · cited 1×
“For example, one study showed that a $1.00 increase in Medicare ’ s fees increases corresponding private prices by $1.16, 37 and another study found that in 2020, employers and private insurers paid 224 percent of what Medicare would have paid for the same services.”
InfluentialNoah, B., Keller, M. S., Mosadeghi, S., Stein, L., Johl, S., Delshad, S., Tashjian, V. C., Lew, D., Kwan, J. T., Jusufagic, A., et al. (2018) · npj Digital Medicine · doi:10.1038/s41746-017-0002-4 · Cited by 273
Whitehead, L., Talevski, J., Fatehi, F., & Beauchamp, A. (2023) · Journal of Medical Internet Research · doi:10.2196/42719 · Cited by 261
McManus, R. J., Little, P., Stuart, B., Morton, K., Raftery, J., Kelly, J., Bradbury, K., Zhang, J., Zhu, S., Murray, E., et al. (2021) · BMJ · doi:10.1136/bmj.m4858 · Cited by 243
Kario, K. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14742 · Cited by 240
Peyroteo, M., Ferreira, I. A., Elvas, L. B., Ferreira, J. C., & Lapão, L. V. (2021) · JMIR mHealth and uHealth · doi:10.2196/28285 · Cited by 190 · cited 1×
“15,16 In addition, regulatory considerations, particularly payment and reimbursement policies, signi fi cantly impact the adoption and potential short-term return on investment (ROI) needed to ensure fi nancial sustainability of RPM-HTN.”
Research works printed but not linked: 1
- Shepard DS, Hodgkin D, Anthony YE. Analysis of hospital costs: a manual for managers. World Health Organization, 2000.
Metadata
- Authors
- Zhang, D. S., Millet, L., Bellows, B. K., Lee, S., & Mann, D.
- Affiliations
- NYU Grossman Long Island School of Medicine (US)
- New York University (US)
- Columbia University Irving Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Zhang, Donglan S
- Venue
- Journal of Telemedicine and Telecare
- Publisher
- SAGE Publications
- Published
- 2026-01-19
- Volume
- 32
- Issue
- 8
- Pages
- 669-678
- ISSN
- 1357-633X (ISSN-L)
- 1758-1109
- PMC
- PMC13016703
- OpenAlex
- W7124691873
- Cited by
- 0
- References
- 30
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Telemedicine and Telecare (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- National Institutes of Health (R01MD013886)
- National Science Foundation (2129076)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- remote patient monitoring, antihypertensive therapy, return on investment, program costs, home blood pressure monitoring, telemedicine, financial sustainability, medication adherence, insurance reimbursement, micro-costing, cardiology
- MeSH terms
- Digital Health, Remote Patient Monitoring, Cost-Benefit Analysis, Humans, Hypertension, United States, Health Care Costs, Telemedicine, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system. https://app.cochat.ai/papers/10.1177/1357633x251403059
- The paper
- Zhang, D. S., Millet, L., Bellows, B. K., Lee, S., & Mann, D. (2026). Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system. Journal of Telemedicine and Telecare. https://doi.org/10.1177/1357633x251403059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.